In its first abortion case since the overturning of Roe v. Wade in 2022, the Supreme Court this week looked unlikely to uphold an appeals court ruling that would dramatically restrict the availability of the abortion pill mifepristone.
Evotec shuts down gene therapy business in light of Q1 2024 loss – Pharmaceutical Technology
Evotec’s group revenues decreased by 2% compared to the same period last year, excluding currency effects, to €208.7m ($226.6m) as per Evotec’s latest Q1 2024